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Abstract
Neutrophils play an important role in the innate immune response to infection with Streptococcus pneumoniae, the
pneumococcus. Pneumococci are phagocytosed by neutrophils and undergo killing after ingestion. Other cellular pro-
cesses may also be induced, including autophagy and the formation of neutrophil extracellular traps (NETs), which may
play a role in bacterial eradication. We set out to determine how these different processes interacted following
pneumococcal infection of neutrophils, and the role of the major pneumococcal toxin pneumolysin in these various
pathways. We found that pneumococci induced autophagy in neutrophils in a type III phosphatidylinositol-3 kinase
dependent fashion that also required the autophagy gene Atg5. Pneumolysin did not affect this process. Phagocytosis
was inhibited by pneumolysin but enhanced by autophagy, while killing was accelerated by pneumolysin but inhibited by
autophagy. Pneumococci induced extensive NET formation in neutrophils that was not influenced by pneumolysin but
was critically dependent on autophagy. While pneumolysin did not affect NET formation, it had a potent inhibitory effect
on bacterial trapping within NETs. These findings show a complex interaction between phagocytosis, killing, autophagy
and NET formation in neutrophils following pneumococcal infection that contribute to host defence against this
pathogen.
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Introduction
Streptococcus pneumoniae (the pneumococcus) is a
Gram-positive bacterium that is a major cause of com-
munity-acquired pneumonia and otitis media, as well as
invasive bacteraemia and meningitis. Despite anti-
biotics and vaccine development, the infection remains
a highly significant cause of morbidity and mortality
worldwide.
One of the most important innate defence mechan-
isms against pneumococci are neutrophils, which rap-
idly migrate to sites of colonization and infection.1–3
Depletion of neutrophils in a mouse model permits
invasive disease to develop, and neutrophil killing of
pneumococci contributes to subsequent adaptive
immune responses.4 A number of immunodeficiencies
and haematological malignancies associated with neu-
tropaenia are also risk factors for invasive pneumococ-
cal disease.5 Taken together, these findings demonstrate
the importance of neutrophils in host defence against
pneumococcal infection.
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Neutrophil killing of pneumococci is not dependent
on reactive oxygen production but principally on serine
proteases.6 Recently, a novel mechanism of neutrophil-
mediated bacterial killing has been described, known as
neutrophil extracellular traps (NETs).7,8 NETs are
formed following neutrophil stimulation, and are
formed of an extracellular web of DNA to which
nuclear constituents such as histones bind, as well as
neutrophil granule proteins. Although originally
thought to result from neutrophil death, evidence now
suggests that NETs can form without substantial
neutrophil necrosis.9,10 Studies on pneumococcal inter-
actions with NETs suggests that the microbe is cap-
tured but not killed by NETs in vitro and in vivo.11
A bacterial endonuclease allows the pneumococci to
escape from the NETs; capsule and d-alanylation of
lipoteichoic acids also protect pneumococci from
NETs. Other studies have suggested that NET forma-
tion in pneumococcal pneumonia may be associated
with enhanced lung damage.12,13
The mechanism of control of NET formation follow-
ing interaction with pathogenic bacteria is not entirely
clear. A variety of pathogens, as well as bacteria com-
ponents such as LPS and cytokines such as IL-8, can
stimulate NET formation by neutrophils,8 as well as
purified pneumolysin, one of the most important
pneumococcal toxins.14 A key intermediate required
for NET generation is the production of reactive
oxygen intermediates, which are lacking in neutrophils
from patients with chronic granulomatous disease, thus
preventing NET formation in this condition.15 Other
studies have also implicated the autophagy pathway
in NET formation.16–18 Autophagy is a highly con-
served cellular mechanism that allows for degradation
of cytoplasmic material and organelles under certain
conditions, allowing for recycling of their constituents.
However, it also plays an important role in infection
and inflammation, playing a role in killing of phagocy-
tosed microbes and down-regulating activation of the
inflammasome.19–21
How these different pathways of intracellular kill-
ing, pneumolysin action, NET formation with bacter-
ial entrapment and induction of autophagy combine
in the interaction of neutrophils with pneumococci is
not clear. We thus set out to determine the role of
each of these processes in the response of human
neutrophils to the pathogenic pneumococcal strain
D39. We found that D39 induced autophagy in
human neutrophils in a classic Atg5 dependent fash-
ion. Pneumolysin reduced the rate of phagocytosis of
pneumococci by neutrophils, but enhanced the rate of
intracellular killing. Autophagy enhanced phagocyt-
osis but reduced the rate of intracellular killing.
NET formation was dependent on autophagy, but
not affected by pneumolysin. However, this toxin
significantly reduced the numbers of bacteria adher-
ent within the NETs.
Materials and methods
Materials
Immunofluorescence analysis of LC3 was performed
using a polyclonal rabbit Ab (APG8B; Abgent, San
Diego, CA, USA); Western blotting was performed
using a polyclonal rabbit Ab (NB100-2220; Novus
Biological, Abingdon, UK).
Bacterial strains
D39 and D39Ply mutant were kindly supplied by
Professor T. Mitchell, University of Birmingham.22
Bacteria were streaked on blood agar plates from
frozen stock and grown overnight (16 h) in 5% CO2.
Purified isolated colonies were transferred to sterile
brain–heart infusion broth (Cat. CM1135;
Thermoscientific Oxoid, Basingstoke, UK). Bacteria
were incubated at 37C for about 6–8 h until grown
to the mid-log phase (OD600, 0.4–0.6) immediately
prior to use. Bacteria were collected by centrifugation
at 3500 g at 4C for 20min, and the pellet washed twice
with sterile PBS. The bacteria were re-suspended in
ice-cold complete RPMI 1640 medium without anti-
biotics. The bacteria were then used for infecting cells
according to the required MOI.
Neutrophil purification
Human neutrophils were isolated from fresh venous
blood obtained from healthy volunteers using a mod-
ified method adapted from Nauseef.23 All procedures
were performed with the ethical approval of Glasgow
University. The neutrophil purity was confirmed by
rapid Romanowski staining before using for experi-
ment and was > 90%.
Neutrophil transfection
Neutrophils were washed and re-suspended in Gene
pulser electroporation buffer (Cat. 165-2676; Bio-Rad
Laboratories, Hercules, CA, USA) at approximately
5 106cells/ml. ON-Target plus human Atg 5 (9474)
siRNA SMART pool (Cat. L-004374-00-0005;
Thermoscientific RNAi Technologies, Paisley, UK)
and control siRNA was added to a final concentration
of 100 nM. The cell suspension was then transferred to
0.4-cm electrode gap sterile Gene-Pulser electropor-
ation cuvettes (Cat. 165-2088; Bio-Rad) on ice.
Electroporation of human neutrophils was performed
using an X-cell Gene-Pulser machine (Bio-Rad) with
settings of capacitance 1000 mF, resistance 1000Ohm
and voltage 250 v, with an exponential decay pulse.
Cells were quickly washed with and re-suspended in
complete RPMI 1640 medium after electroporation.
The medium was supplemented with 10% heat-
inactivated human serum and GM-CSF (10 ng/ml).
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The cells were then incubated at 37C, 5% CO2 over-
night. Viability was determined by 7-aminoactinomycin
D staining and analysis by flow cytometry; viability
remained at > 85% following electroporation.
Rates of neutrophil phagocytosis and killing
Human neutrophils were isolated according the proto-
col described above. Cells were re-suspended at
1 106cells/ml in complete RPMI 1640 medium con-
taining heat-inactivated human serum. Cells were
infected with S. pneumoniae at an MOI of 10 and incu-
bated at 37C and 5% CO2. The same numbers of bac-
teria were grown in a second tube in the same medium
as a control. The tubes were rotated end to end slowly
and 1ml infected neutrophils and bacterial suspension
were collected at different time points (0–120min).
Infected neutrophils were centrifuged at 100 g for
5min. The supernatant containing bacteria was col-
lected in a tube and the neutrophil pellet was washed
twice with PBS to remove any extracellular bacteria.
The above procedure was repeated during each time
point. Internalized bacteria were enumerated neutro-
phils by re-suspending the neutrophil pellet in 1ml
PBS containing 0.05% (w/v) saponin (Cat. 47036-
50G-F; Sigma-Aldrich, St. Louis, MO, USA) on ice.
The cell lysates were homogenized by gentle pipetting,
serially diluted and incubated on the blood agar over-
night. The number of bacteria in each sample from
control, supernatant and cell lysates was enumerated
by colony counting.
The method of Hampton et al. was used to derive the
rates of phagocytosis and killing.24 Analysis was per-
formed using a spread sheet available from the
Hampton group at http://www.otago.ac.nz/free-radical/
research/otago599670.html.
The uptake by phagocytosis and killing of bacteria
by neutrophils occurs in series as described by
equation (1):
A kp !B kk !C ð1Þ
where A is the number of extracellular bacteria, B is the
number of viable intracellular bacteria, C is the number
of killed bacteria, kp is the rate constant of phago-
cytosis, and k
k the rate constant of killing. Assuming first-order kin-
etics gives the following differential equations:
d ½A
dt
¼ kp½A ð2Þ
d ½B
dt
¼ kp½A  kk½B ð3Þ
where t is time.
Solving:
A ¼ A0ekpt ð4Þ
where A0 is the original number of bacteria added.
Hence, kp can be derived from the slope of ln(A) vs.
time.
B ¼ A0kpðkk  kpÞ ðe
kpt  ekktÞ ð5Þ
kk can be determined at each time point by rearranging
and solving equation [5] using the Lambert W function
as described in the spread sheet referenced above.
An average value is then calculated for all the different
times.
LDH killing assay was performed using a Cytotox-
96 kit (Promega, Southampton, UK).
NET analysis
NETS were analysed using a modified protocol.7
Purified human neutrophils were seeded onto 13-mm
sterile glass coverslips at a density of 4 105cells per
ml in RPMI containing 2% heat-inactivated human
serum. Cells were infected with bacteria and left at
37C in 5% CO2 for 4 h before gentle fixation in 4%
paraformaldehyde in PBS for 60min. Cells were
washed by inverting onto drops of PBS on parafilm,
permeabilized with 0.5% Triton-X 100 using the same
method and then blocked by inverting onto drops of
10% normal goat serum in PBS. After further washing
they were then incubated with anti-neutrophil elastase
(Abcam, Cambridge, UK) for 60min followed by
washing and secondary Ab visualization using the
same method of inversion onto drops. DNA was coun-
terstained using DAPI or Sytox Orange; bacteria were
visualized by prior loading with eFluor 450 at 40 mM
for 15min (eBioscience, San Diego, CA, USA) before
washing twice in PBS. Slides were viewed with a Zeiss
Axiovert S100 microscope using OpenLab software
(Perkin Elmer, Wokingham, UK). NET formation
was quantified by direct visualization of the stained
cells. Total cell counts were determined per field of
view by their DNA stain. The cells that had undergone
NETosis were classified as having extracellular material
staining with neutrophil elastase. At least three views of
100 cells were counted and the mean percentage
( SEM) were calculated. We found that many of the
neutrophils formed NETs from cells in close proximity,
which would be underestimated by automatic counting
procedures.
Statistics
Differences between groups were tested using unpaired
t-tests with Prism (GraphPad, La Jolla, CA, USA).
A P-value< 0.05 was taken as significant.
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Results
S. pneumoniae induces autophagy in human
neutrophils
Firstly, we incubated purified human neutrophils with
the D39 strain of pneumococcus for various times and
assayed for the induction of autophagy by the detection
of puncta containing the autophagocytic vacuole
marker LC3. Following infection, there was a signifi-
cant increase in the numbers of LC3 puncta per cell,
both with wild type D39 and an isogenic mutant
lacking pneumolysin (D39Ply), to the same degree
as seen after treatment with rapamycin, an inhibitor
of the mechanistic target of rapamycin (Figure 1a).
Pneumolysin had no effect on autophagy induction.
We also measured the conversion of LC3 from its
native (LC3-I) to its lipidated form (LC3-II), a post-
translational modification that occurs following induc-
tion of autophagy. Again, following infection with the
D39 strain of pneumococcus we observed a marked
increase in the levels of LC3-II relative to b-tubulin
that increased over time, again with no significant
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Figure 1. Neutrophils undergo autophagy following infection with pneumococcus. Neutrophils were left untreated (Basal, or ‘B’) or
infected with wild type pneumococcal strain D39 (D39WT) or with the Ply-deficient mutant (D39Ply) at a multiplicity of infection of
10 for 4 h, or treated with Rapamycin (Rapa, or ‘R’) at a concentration of 50mg/ml for 4 h. Accumulation of LC3 staining puncta was
visualized by immunofluorescence as shown in (a), and quantified as shown in (b). Results are the means of triplicate determinations
from at least 60 cells; error bars are SEM. (c) Lysates from cells treated as indicated for the times shown were immunoblotted for LC3
(upper panel) or b-tubulin (lower panel). Position of the different LC3 forms is shown to the left and molecular mass markers at the
right. (d) Mean values of the ratio between density of LC3-II band to b-tubulin for treatments after 4 h, as indicated. Values are the
means of 2–3 separate determinations; error bars are SEM. (e) as (c), but with addition of the inhibitors E64d (10 mg/ml) and pepstatin-
A (10mg/ml) as shown and incubation for 4 h. The lower panel shows values of the ratio between density of LC3-II band to b-tubulin
for treatments as indicated. Experiment repeated with similar findings. In (b) and (d) significant differences from the basal level were
determined by t-tests; *P< 0.05, **P< 0.01. Difference between D39WT and D39Ply was not significant (ns).
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difference between the wild type D39 and the D39Ply
mutant (Figure 1b, c).
To ensure the changes in the levels of LC3-II were
due to increased flux through the autophagocytic path-
way rather than inhibition of autophagosome degrad-
ation, we repeated this assay in the presence of the
lysosomal protease inhibitors. E64d and pepstatin A
(Figure 1d). These inhibitors prevent lysosomal degrad-
ation and thus will reveal if the increase in LC3-II is due
to increased formation of autophagosomes. In the pres-
ence of these inhibitors, we observed increased levels of
LC3-II confirming an increased flux through the autop-
hagocytic pathway following infection with D39.
Importantly, over the time course (4 h) of these
Basal(a)
(b)
(c)
(d)
β-tubulin
β-tubulin
Control
LC3-I
LC3-I
3MA (10mM)
LC3-II
LC3-II
B D39 D39DPly DPlyR B R
B D39 D39DPly DPlyR B R
B D39 D39DPly DPlyR B R
B B D39 D39DPly DPlyR B
B D39 D39DPly DPlyR B R
B B D39 D39DPly DPlyR B
3MA (10mM)
3MA (10mM)
15
2.5
2.0
1.5
1.0
0.5
0.0
– – – – + + + +
–
– – – – –
–– – – + + +
+ + +
10
5
0
15
10
5
0
2.5
2.0
1.5
1.0
0.5
0.0
**
**
**
*
*
*
****
**
3MA
(0mM)
3MA
(10mM)
LC
3+
 P
un
ct
a/
 c
el
l
LC
3+
 P
un
ct
a/
 c
el
l
LC
3-
II/
 β-
tu
bu
lin
LC
3-
II/
 β-
tu
bu
lin
Rapa D39 WT D39DPly
Basal
Control
siRNA
Control siRNA
Atg5
siRNA
Atg5 siRNA
Atg5
Atg5 siRNA
Control siRNA Atg5 siRNA
Rapamycin D39 WT D39DPly
17 kDa
15 kDa
55 kDa
17 kDa
15 kDa
56 kDa
55 kDa
Figure 2. Autophagy following pneumococcal infection of neutrophils is dependent on type III PI3K and Atg5. Neutrophils were
infected or treated with rapamycin as in Figure 1. (a) Immunofluorescence images of neutrophils treated as shown in the absence or
presence of the type III PI3K inhibitor 3-methyladenine (3MA). Panel to the right shows quantification of the puncta as described in
Figure 1. (b) Immunoblot of neutrophil lysates treated as shown and as described in Figure 1. Panel to the right shows quantification of
repeats of the experiment as in Figure 1. (c) and (d) as (a) and (b), respectively, but with cells treated with siRNA to Atg5 or control
siRNA as indicated. Significant differences from the corresponding level in the absence of the inhibitor were determined by t-tests;
*P< 0.05, **P< 0.01.
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infections, cell viability remained > 90%, as measured
by release of lactate dehydrogenase (data not shown).
The increase in LC3-II levels in the presence of the
lysosomal inhibitors was reproducible, although there
was considerable variation in the absolute values of the
LC3-II/b-tubulin ratio, precluding a valid statistical
test of the increase observed. However, we also saw
the same increase in LC3-II formation after D39 infec-
tion in the presence of bafilomycin, a different lyso-
somal inhibitor (data not shown).
Autophagy following pneumococcal infection is
inhibited by 3-methyladenine and requires Atg5
Next, we tested the effect of the type III phosphatidy-
linositol 3-kinase inhibitor (PI3K), 3-methyladenine
(3MA)25 on autophagy following pneumococcal
infection of neutrophils. The type III PI3K activates
autophagy through production of phosphatidylinosi-
tol-3-phosphate that recruits essential autophagy pro-
teins required for formation of the autophagocytic
vacuole.26 Treatment of neutrophils with 3MA signifi-
cantly abrogated the production of LC3 containing
puncta in cells following pneumococcal infection
(Figure 2a). It also significantly inhibited the conver-
sion of LC3-I to LC3-II (Figure 2b), consistent with its
known effects on inhibiting the classical pathway of
autophagy.
To explore the mechanism of pneumococcal-induced
autophagy further, we tested the effect of silencing the
product of the essential autophagy gene Atg5 on autop-
hagy following pneumococcal infection. Compared
with control siRNA, siRNA to Atg5 significantly inhib-
ited the formation of LC3 puncta following treatment
of cells with rapamycin or following pneumococcal
infection (Figure 2c). We also analysed the effect of
Atg5 silencing on the conversion of LC3-I to LC3-II.
Following autophagy induction by rapamycin or
pneumococcal infection, the Atg5 protein was signifi-
cantly induced (Figure 1d, left panel), as has previously
been described.27 Note these blots show the conjugate
of Atg5 with Atg12 that forms on induction of autop-
hagy.28 Again, compared with control siRNA, siRNA
to Atg5 produced a significant inhibition of Atg5 induc-
tion, and inhibited conversion of LC3-I to LC3-II
(Figure 2d). In all these experiments, neutrophil viabil-
ity remained > 90% (data not shown).
Effects of pneumolysin and autophagy on the
kinetics of phagocytosis and intracellular killing
of pneumococci
We then measured the effects of pneumolysin and autop-
hagy on the rates of uptake and killing of the D39
pneumococcal strain by neutrophils. We used a single-
step assay for measuring these parameters as developed
by the Hampton group.24,29,30 This method uses a kinetic
model to determine the rate constant of phagocytosis
(kp) and killing (kk). Figure S1 shows the individual
data values at the various time points in the experimental
incubation of pneumococci with neutrophils used to
derive the mean values for each constant. These mean
values of kp and kk are shown in Figure 3. Firstly, we
measured these kinetic constants in D39 WT and the
D39Ply pneumolysin deficient mutant. kp was signifi-
cantly increased in the D39Ply mutant, showing that
pneumolysin normally acts to reduce the rate of phago-
cytosis by human neutrophils. kk, however, was signifi-
cantly reduced in the D39Ply mutant, showing that the
effect of pneumolysin is to increase the rate of intracel-
lular killing.
Next, we calculated these rate constants for pneumo-
coccal interaction with neutrophils in the presence of
the autophagy inhibitor 3MA and with knockdown of
the Atg5 gene. The results from these determinations
were very similar and showed that when autophagy was
inhibited by either mechanism, the rate of phagocytosis
was significantly reduced but the rate of intracellular
killing was increased (Figure 3). These results are con-
sidered further in the discussion.
*
***
***
***
**
**
20
D39
3MA
Control siRNA
30(a)
(b)
R
at
e 
of
 p
ha
go
cy
to
sis
(10
3  
x 
m
in
–
1 )
R
at
e 
of
 k
illi
ng
(10
1  
x 
m
in
–
1 )
20
10
10
5
0
+
+
+ + + +–
+ –
– –
– –
– –
– –
– –
– –
– –
– –
–
+
–
+
–
15
0
D39DPly
siRNA Atg5 
Figure 3. Rates of neutrophil phagocytosis and killing of
pneumococci. Cells were treated as indicated and rates of
phagocytosis (a) and killing (b) determined as described in
‘Material and methods’. Columns are the means from three (a) or
five (b) determinations; error bars are 95% confidence limits
(a) or SEM (b). Significant differences between the observations
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NET formation following pneumococcal infection is
dependent on autophagy but not on pneumolysin
We analysed neutrophils following infection for the
presence of NETS. Using immunofluorescent micro-
scopy, we identified NETs by the presence of extracel-
lular DNA coated with elastase, a neutrophil granule
protein. Following incubation of neutrophils with
D39, there was a marked and significant induction
of NET formation, to a degree very similar to
that produced by the known NET inducer, PMA
(Figure 4a). We quantified the degree of NET forma-
tion both form the D39WT strain, as well as the
D39Ply mutant (Figure 4b). Both strains showed
a significant induction of NETs, but there no differ-
ence between them.
We then determined the influence of autophagy on
this NET formation, using the inhibitor 3MA as well as
silencing of the Atg5 gene (Figure 5). Using both meth-
ods (Figure 5b), we found that down-regulation of
autophagy significantly reduced NET formation,
almost to baseline values, demonstrating that autop-
hagy is essential to NET formation following pneumo-
coccal infection of human neutrophils.
Influence of pneumolysin on pneumococcal
trapping by NETs
In the experiments analysing NET formation with the
D39WT and D39Ply mutant, we noted there were
apparently far fewer bacteria associated with NETs fol-
lowing infection with the D39WT strain compared with
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Figure 4. NET formation following pneumococcal infection of neutrophils. (a) Immunofluorescent images of neutrophils treated or
infected as shown and stained for DNA (DAPI, blue), elastase (green) and merged. (b) quantification of NET formation as described in
the ‘Materials and methods’. Results are means of triplicate determinations from views of at least 100 cells; error bars are SEM.
Significant differences from basal levels are shown using the same symbols and statistical tests as Figure 1.
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the D39Ply mutant. We quantified this difference
(Figure 6), which confirmed there was a significant
increase in the numbers of bacteria associated with
NETs following infection of human neutrophils with
the D39Ply mutant strain compared with the D39
WT. Thus, pneumolysin acts to inhibit pneumococcal
association with NETs.
Discussion
Neutrophils play a fundamental role in the innate
immune response to pneumococcal infection. Our
results highlight a number of important mechanisms
underlying the interaction of the microbe with these
cells. We show that pneumococci induce autophagy
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Figure 4.
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in human neutrophils in a classical type III PIK and
Atg5-dependent fashion that is not dependent on pneu-
molysin. A previous report studying pneumococcal
infection of A549 cells found that pneumolysin did
play a role in autophagy induction.17 The transformed
cell line A549 is said to synthesize large amounts of
intracellular lipid,31 which may influence its inter-
actions with the cholesterol-dependent cytolysin pneu-
molysin. This might account for the differences
observed between A549 cells and our studies with pri-
mary human neutrophils.
Neutrophil phagocytosis of pneumococci is a key
element of host defence. The data presented here
show that pneumolysin inhibits the rate of phagocytosis
by human neutrophils. A previous study showed that
pneumolysin inhibited complement deposition on the
surface of pneumococci and led to decreased phagocyt-
osis.32 In our experiments, we used heat-inactivated
human serum, thus suggesting effects on complement
are not responsible. We also observed that pneumolysin
increased the rate of intracellular killing within
neutrophils. Although purified pneumolysin is reported
to inhibit the neutrophil respiratory burst,33,34 release
of pneumolysin from pneumococci by autolysis has
been shown strongly to induce neutrophil oxygen rad-
ical production.35 This latter effect would account for
the increased neutrophil killing in the presence of bac-
teria expressing pneumolysin observed here.
Our data show that autophagy enhances the rate of
neutrophil phagocytosis of pneumococci. Previous
reports have suggested that autophagy reduced the
rate of macrophage phagocytosis of particles and
mycobacteria.36,37 However, a novel form of phagocyt-
osis, termed LC3-associated phagocytosis, has recently
been described which utilizes the autophagocytic
machinery to augment phagocytosis in a type III
PI3K and Atg5-dependent fashion.38 This may account
for the autophagy-enhanced phagocytosis observed
here. The rates of intracellular killing, however, were
reduced by autophagy in pneumococcal-infected neu-
trophils. This was surprising, as previous studies have
suggested that autophagy augments neutrophil killing
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Figure 6. Pneumolysin inhibits bacterial capture by NETs. As in Figure 4, but with bacteria pre-loaded with eFluor 450 for visu-
alization. (a) Immunofluorescent staining. (b) Quantification of the number of bacteria captured per NET. Columns are the means from
three separate determinations of at least 20 NETs; error bars are SEM. Values for the Ply-deficient mutant (D39Ply) are significantly
different from the D39WT (t-test, P< 0.05).
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of the Gram-positive pathogen Bacillus anthracis.39
However, a number of pathogens have been shown to
benefit from autophagy by nutrient acquisition;40 this
may be the mechanism operative here.
We show that the pneumococcus is a potent stimu-
lator of NET formation from neutrophils that is
dependent on autophagy. Pneumolysin was not
required for NET formation. A number of previous
studies have suggested that autophagy is required for
NET formation.16–18 The data reported here are the
first demonstration that autophagy is essential for
NET formation following pneumococcal infection of
human neutrophils. The mechanism underlying the
influence of autophagy on NET formation is not
clear. In our study, NETosis was not associated with
significant neutrophil death, as has been described by
others.9,10 We speculate that release of nuclear and
granule components from viable cells must utilize the
autophagocytic pathway in some way.
We were surprised to find that pneumolysin inhib-
ited NET capture of pneumococci. Previous studies
have suggested that NETs capture but do not kill pneu-
mococci.11,41 The mechanism by which pneumolysin
acts to promote NET evasion by pneumococci is not
clear. A recent report has found that pneumolysin is
required for biofilm formation by the pneumococcus.42
We speculate that pneumolysin-induced biofilm forma-
tion may act to prevent capture of pneumococci by
NETs and account for the observations reported here.
Clearance of pneumococci by neutrophils is a major
component of the innate immune defence against
pneumococcal colonization and infection. Our results
show the complex interplay between pneumolysin
expression, autophagy, phagocytosis, intracellular kill-
ing, and NET formation and capture of bacteria. Some
of these responses have augmenting effects on one neu-
trophil process while down-regulating another.
Pathogens such as the pneumococcus have evolved
many sophisticated methods to evade immune clear-
ance, and this has contributed to the complex interplay
between the various factors highlighted in this study.
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